Cancer remains one of the leading causes of death worldwide, yet survival rates have improved dramatically over the past several decades. According to the National Cancer Institute (NCI), the overall five-year cancer survival rate in the United States has risen from approximately 49% in the mid-1970s to nearly 68% today. This progress reflects breakthroughs in early detection, surgical techniques, chemotherapy regimens, targeted therapies, and immunotherapy.

The American Cancer Society (ACS) estimates approximately 2 million new cancer cases are diagnosed in the United States each year. Understanding your specific cancer type, stage, and available treatment options is a critical first step in navigating a cancer diagnosis.

Key Fact: Advances in precision medicine now allow oncologists to tailor treatment plans based on the genetic profile of a tumor, not just its location in the body. Targeted therapies and immunotherapies have transformed outcomes for many cancer types that were previously difficult to treat.

Understanding Cancer Treatment

Modern cancer treatment typically involves one or more of the following approaches, often used in combination:

  • Surgery — Physical removal of the tumor and surrounding tissue. Often the first-line treatment for solid tumors detected at an early stage.
  • Chemotherapy — Systemic drugs that kill rapidly dividing cells. May be given before surgery (neoadjuvant), after surgery (adjuvant), or as primary treatment. Learn more about chemotherapy.
  • Radiation therapy — High-energy beams targeted at the tumor site. Used alone or alongside surgery and chemotherapy. Learn more about radiation therapy.
  • Targeted therapy — Drugs designed to attack specific molecular targets on cancer cells, such as HER2 or EGFR mutations.
  • Immunotherapy — Treatments that harness the body's immune system to recognize and destroy cancer cells, including checkpoint inhibitors and CAR-T cell therapy.
  • Hormone therapy — Blocks or lowers hormones that fuel certain cancers, particularly breast and prostate cancer.
  • Bone marrow transplant — Replaces damaged bone marrow with healthy stem cells, primarily used for blood cancers like leukemia and lymphoma.

Cancer Types

Select a cancer type below for a comprehensive guide covering risk factors, staging, treatment options, and survival rates.

Breast Cancer

The most common cancer in women worldwide. Covers DCIS, IDC, ILC, triple-negative and HER2-positive subtypes, along with surgical options, chemotherapy, hormone therapy and targeted treatments.

Lung Cancer

The leading cause of cancer death. Covers non-small cell (NSCLC) and small cell (SCLC) types, staging, surgery, chemotherapy, targeted therapy with EGFR/ALK inhibitors, and immunotherapy.

Prostate Cancer

The most common cancer in men. Covers Gleason scoring, PSA testing, active surveillance, radical prostatectomy, radiation therapy, and hormone therapy for advanced disease.

Colorectal Cancer

The third most common cancer overall. Covers screening with colonoscopy, polyp-to-cancer progression, surgical resection, FOLFOX/FOLFIRI chemotherapy, and targeted agents.

Bladder Cancer

Covers non-muscle-invasive versus muscle-invasive disease, BCG immunotherapy, TURBT, radical cystectomy, chemotherapy, and emerging checkpoint inhibitor treatments.

Leukemia

Blood cancers including ALL, AML, CLL and CML. Covers chemotherapy regimens, bone marrow transplant, targeted therapies like imatinib, and CAR-T cell therapy.

Kidney Cancer

Renal cell carcinoma and its subtypes. Covers partial and radical nephrectomy, targeted therapies (sunitinib, cabozantinib), immunotherapy combinations, and surveillance protocols.

Ovarian Cancer

Often diagnosed at advanced stages. Covers epithelial, germ cell, and stromal types, debulking surgery, platinum-based chemotherapy, PARP inhibitors, and BRCA testing.

Liver Cancer

Hepatocellular carcinoma and risk factors including hepatitis and cirrhosis. Covers surgical resection, liver transplant, ablation, TACE, and systemic therapies.

Pancreatic Cancer

One of the most challenging cancers to treat. Covers Whipple procedure, FOLFIRINOX and gemcitabine-based regimens, radiation, and emerging clinical trial approaches.

Stomach Cancer

Gastric cancer types, risk factors including H. pylori infection, gastrectomy, perioperative chemotherapy, HER2-targeted therapy, and immunotherapy options.

Mesothelioma

Asbestos-related cancer of the pleura or peritoneum. Covers pleurectomy, extrapleural pneumonectomy, multimodal treatment, and the nivolumab-ipilimumab combination.

Esophageal Cancer

Adenocarcinoma and squamous cell types. Covers endoscopic resection, esophagectomy, chemoradiation, and emerging immunotherapy approaches for advanced disease.

Uterine Cancer

Endometrial cancer and uterine sarcomas. Covers hysterectomy, radiation, hormone therapy, chemotherapy, and the role of mismatch repair deficiency testing.

The Importance of Early Detection

Cancer screening can detect cancers before symptoms appear, when treatment is most effective. The ACS recommends routine screening for several common cancers:

Cancer Type Screening Method Recommended Starting Age
Breast cancer Mammogram Age 40 (annual or biennial)
Colorectal cancer Colonoscopy or stool-based test Age 45
Lung cancer Low-dose CT scan (high-risk individuals) Age 50 with 20+ pack-year history
Prostate cancer PSA blood test (shared decision-making) Age 50 (45 for high-risk groups)

View our complete cancer screening guide for detailed recommendations and risk-based screening schedules.

Medical Disclaimer: The information on this page is intended for educational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. Sources include the National Cancer Institute (cancer.gov) and the American Cancer Society (cancer.org).